Identification of genes associated with sensitivity to 5-flourouracil and cisplatin in hepatoma cells

Yujin Hoshida, Masaru Moriyama, Motoyuki Otsuka, Naoya Kato, Tadashi Goto, Hiroyoshi Taniguchi, Yasushi Shiratori, Naohiko Seki, Masao Omata

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Background: The prognosis of patients with advanced hepatoma is grim. Although chemotherapy is adapted to such patients, the efficacy is low and the outcome cannot be predicted before therapy. In this study, we aimed to identify genes associated with sensitivity to 5-fluorouracil and cisplatin, drugs widely used in treatment, using gene expression profiles. Methods: Gene expression was evaluated in eight human hepatoma cell lines using an in-house cDNA microarray including 2300 known genes. The 50% growth inhibitory concentrations (GI50) of 5-fluorouracil and cisplatin were measured by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay and designated as chemosensitivity. Genes with expression ratios associated with GI50 were selected using the permutation test. Results: For 5-fluorouracil and cisplatin, 21 and 40 genes, respectively, were selected. From among the genes associated with 5-fluorouracil and cisplatin, several encoding metabolic enzymes were selected. In addition, several genes involved in the cell cycle and transcription were identified. Conclusions: We identified genes that may be associated with sensitivity to 5-fluorouracil and cisplatin. A list of these genes may be useful to elucidate how these drugs work on human hepatoma.

Original languageEnglish (US)
Pages (from-to)92-95
Number of pages4
JournalJournal of Gastroenterology
Volume37
Issue numberSUPPL. 14
StatePublished - Nov 1 2002
Externally publishedYes

Fingerprint

Cisplatin
Hepatocellular Carcinoma
Fluorouracil
Genes
Gene Expression
Oligonucleotide Array Sequence Analysis
Transcriptome
Pharmaceutical Preparations
Inhibitory Concentration 50
Cell Cycle
Drug Therapy
Cell Line
Enzymes
Therapeutics
Growth

Keywords

  • 5-fluorouracil
  • Chemosensitivity
  • Cisplatin
  • Gene expression

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Hoshida, Y., Moriyama, M., Otsuka, M., Kato, N., Goto, T., Taniguchi, H., ... Omata, M. (2002). Identification of genes associated with sensitivity to 5-flourouracil and cisplatin in hepatoma cells. Journal of Gastroenterology, 37(SUPPL. 14), 92-95.

Identification of genes associated with sensitivity to 5-flourouracil and cisplatin in hepatoma cells. / Hoshida, Yujin; Moriyama, Masaru; Otsuka, Motoyuki; Kato, Naoya; Goto, Tadashi; Taniguchi, Hiroyoshi; Shiratori, Yasushi; Seki, Naohiko; Omata, Masao.

In: Journal of Gastroenterology, Vol. 37, No. SUPPL. 14, 01.11.2002, p. 92-95.

Research output: Contribution to journalArticle

Hoshida, Y, Moriyama, M, Otsuka, M, Kato, N, Goto, T, Taniguchi, H, Shiratori, Y, Seki, N & Omata, M 2002, 'Identification of genes associated with sensitivity to 5-flourouracil and cisplatin in hepatoma cells', Journal of Gastroenterology, vol. 37, no. SUPPL. 14, pp. 92-95.
Hoshida Y, Moriyama M, Otsuka M, Kato N, Goto T, Taniguchi H et al. Identification of genes associated with sensitivity to 5-flourouracil and cisplatin in hepatoma cells. Journal of Gastroenterology. 2002 Nov 1;37(SUPPL. 14):92-95.
Hoshida, Yujin ; Moriyama, Masaru ; Otsuka, Motoyuki ; Kato, Naoya ; Goto, Tadashi ; Taniguchi, Hiroyoshi ; Shiratori, Yasushi ; Seki, Naohiko ; Omata, Masao. / Identification of genes associated with sensitivity to 5-flourouracil and cisplatin in hepatoma cells. In: Journal of Gastroenterology. 2002 ; Vol. 37, No. SUPPL. 14. pp. 92-95.
@article{b8f83e720a5b403dbea9eef90ce6a633,
title = "Identification of genes associated with sensitivity to 5-flourouracil and cisplatin in hepatoma cells",
abstract = "Background: The prognosis of patients with advanced hepatoma is grim. Although chemotherapy is adapted to such patients, the efficacy is low and the outcome cannot be predicted before therapy. In this study, we aimed to identify genes associated with sensitivity to 5-fluorouracil and cisplatin, drugs widely used in treatment, using gene expression profiles. Methods: Gene expression was evaluated in eight human hepatoma cell lines using an in-house cDNA microarray including 2300 known genes. The 50{\%} growth inhibitory concentrations (GI50) of 5-fluorouracil and cisplatin were measured by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay and designated as chemosensitivity. Genes with expression ratios associated with GI50 were selected using the permutation test. Results: For 5-fluorouracil and cisplatin, 21 and 40 genes, respectively, were selected. From among the genes associated with 5-fluorouracil and cisplatin, several encoding metabolic enzymes were selected. In addition, several genes involved in the cell cycle and transcription were identified. Conclusions: We identified genes that may be associated with sensitivity to 5-fluorouracil and cisplatin. A list of these genes may be useful to elucidate how these drugs work on human hepatoma.",
keywords = "5-fluorouracil, Chemosensitivity, Cisplatin, Gene expression",
author = "Yujin Hoshida and Masaru Moriyama and Motoyuki Otsuka and Naoya Kato and Tadashi Goto and Hiroyoshi Taniguchi and Yasushi Shiratori and Naohiko Seki and Masao Omata",
year = "2002",
month = "11",
day = "1",
language = "English (US)",
volume = "37",
pages = "92--95",
journal = "Journal of Gastroenterology",
issn = "0944-1174",
publisher = "Springer Japan",
number = "SUPPL. 14",

}

TY - JOUR

T1 - Identification of genes associated with sensitivity to 5-flourouracil and cisplatin in hepatoma cells

AU - Hoshida, Yujin

AU - Moriyama, Masaru

AU - Otsuka, Motoyuki

AU - Kato, Naoya

AU - Goto, Tadashi

AU - Taniguchi, Hiroyoshi

AU - Shiratori, Yasushi

AU - Seki, Naohiko

AU - Omata, Masao

PY - 2002/11/1

Y1 - 2002/11/1

N2 - Background: The prognosis of patients with advanced hepatoma is grim. Although chemotherapy is adapted to such patients, the efficacy is low and the outcome cannot be predicted before therapy. In this study, we aimed to identify genes associated with sensitivity to 5-fluorouracil and cisplatin, drugs widely used in treatment, using gene expression profiles. Methods: Gene expression was evaluated in eight human hepatoma cell lines using an in-house cDNA microarray including 2300 known genes. The 50% growth inhibitory concentrations (GI50) of 5-fluorouracil and cisplatin were measured by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay and designated as chemosensitivity. Genes with expression ratios associated with GI50 were selected using the permutation test. Results: For 5-fluorouracil and cisplatin, 21 and 40 genes, respectively, were selected. From among the genes associated with 5-fluorouracil and cisplatin, several encoding metabolic enzymes were selected. In addition, several genes involved in the cell cycle and transcription were identified. Conclusions: We identified genes that may be associated with sensitivity to 5-fluorouracil and cisplatin. A list of these genes may be useful to elucidate how these drugs work on human hepatoma.

AB - Background: The prognosis of patients with advanced hepatoma is grim. Although chemotherapy is adapted to such patients, the efficacy is low and the outcome cannot be predicted before therapy. In this study, we aimed to identify genes associated with sensitivity to 5-fluorouracil and cisplatin, drugs widely used in treatment, using gene expression profiles. Methods: Gene expression was evaluated in eight human hepatoma cell lines using an in-house cDNA microarray including 2300 known genes. The 50% growth inhibitory concentrations (GI50) of 5-fluorouracil and cisplatin were measured by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay and designated as chemosensitivity. Genes with expression ratios associated with GI50 were selected using the permutation test. Results: For 5-fluorouracil and cisplatin, 21 and 40 genes, respectively, were selected. From among the genes associated with 5-fluorouracil and cisplatin, several encoding metabolic enzymes were selected. In addition, several genes involved in the cell cycle and transcription were identified. Conclusions: We identified genes that may be associated with sensitivity to 5-fluorouracil and cisplatin. A list of these genes may be useful to elucidate how these drugs work on human hepatoma.

KW - 5-fluorouracil

KW - Chemosensitivity

KW - Cisplatin

KW - Gene expression

UR - http://www.scopus.com/inward/record.url?scp=0036854730&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036854730&partnerID=8YFLogxK

M3 - Article

C2 - 12572874

AN - SCOPUS:0036854730

VL - 37

SP - 92

EP - 95

JO - Journal of Gastroenterology

JF - Journal of Gastroenterology

SN - 0944-1174

IS - SUPPL. 14

ER -